We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 13
Most popular |Most recent


Digital health investment maintains momentum in 2015

USA - May 1 2015 Digital health investment is off to a healthy start in 2015 with our friends at Rock Health reporting more than $630 million invested in the first...

Jake Handy, Michael T. Esquivel, Ewa M. Davison, Kevin Kabler, Stephen M. Graham.


Will Namenda IR withdrawal force a legal switch on product hopping?

USA - October 3 2014 On September 15, 2014, New York Attorney General Eric Schneiderman filed an anti-trust lawsuit against the specialty pharmaceutical company Forest...


Unanimous Supreme Court decision in Ass'n for Mol. Pathology v. Myriad Genetics Inc.

USA - June 13 2013 Today, a unanimous Supreme Court decision in Ass'n for Mol. Pathology v. Myriad Genetics, Inc., held that Myriad's claims directed to "a naturally...

Lynn H. Pasahow, Carolyn Chang, Pauline Farmer-Koppenol.


Seeds of exhaustion: Monsanto is coming to the United States Supreme Court

USA - October 8 2012 On October 5, the United States Supreme Court agreed to review the case Bowman v. Monsanto Co., Docket No. 11-796 (USSC 2012)....


Threading the needle between divided infringement issues and patentable subject matter

USA - June 15 2012 Personalized medicine is an emerging approach to medical practice that carries the promise of effective, individualized treatment....

Michelle Lee,.